NCT03172299 2025-03-24
PROTECT
Centre Hospitalier Universitaire de Nice
Phase 3 Completed
Clinical Trials
6 trialsNCT02678572 2023-12-21
FOCUS
Delcath Systems Inc.
Phase 3 Completed
NCT02843386 2022-08-31
FOTEADJ
Institut Curie
Phase 3 Completed
NCT00324727 2021-06-21
Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma
Delcath Systems Inc.
Phase 3 Completed
NCT01989572 2020-07-07
Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery
National Cancer Institute (NCI)
Phase 3 Completed
NCT00680225 2017-04-12
Lucentis as an Adjuvant Therapy With TTT-ICG Based in Choroidal Melanoma
New England Retina Associates
Phase 3 Completed